T/CAPC 012-2023 Active

Scope: This document is applicable to retail pharmacies providing pharmaceutical services for patients with diabetes, hypertension, and dyslipidemia (hereinafter referred to as "the three highs"). The pharmaceutical service targets patients with a clear diagnosis of the three highs who receive home-based drug treatment. Main technical content: Retail pharmacies should fully recognize that the three highs in China are the three main risk factors for the incidence and mortality of cardiovascular diseases. Based on the characteristics of a large number of patients with the three highs in China and a low control rate, retail pharmacies should give full play to their role in chronic disease management and provide standardized, continuous, and full-course pharmaceutical services for patients with the three highs. By collecting patient information, evaluating interventions, providing medication guidance, patient education, home follow-ups, and establishing medical records, pharmacies can enhance patients' correct understanding of the disease and medication adherence, improve their self-management ability and develop good living habits, reduce the overall risk of cardiac, cerebral, renal, and vascular complications and mortality in patients with the three highs, and improve their quality of life.